Last Updated: 10 Nov 2024
Executive Summary
ReMax Holding (RMAX) is a franchisor of real estate and mortgage brokerage services with a global presence. The company has a market capitalization of $387.239 million and its latest stock price is $12.32. Despite a negative EPS of -$0.52, the company has a strong PEGRatio of 4.07, indicating potential for future growth. Analysts rate the stock as a "Hold" with a target price of $9.75.
Company Overview
RE / MAX Holdings, Inc. is headquartered in Denver, Colorado and operates in the United States, Canada, and internationally. The company provides franchising, brokerage, and technology services to its franchisees. ReMax Holding has a network of over 140,000 agents in more than 110 countries.
Fundamental Analysis
Revenue: RMAX reported revenue of $311.818 million for the trailing twelve months (TTM), showing a slight decrease of -0.034% year-over-year.
Gross Profit: The company's gross profit for the TTM was $263.067 million, with a profit margin of -0.0308.
Operating Margin: RMAX has an operating margin of 0.188 for the TTM.
Diluted EPS: The diluted EPS for the TTM is -$0.52.
Book Value: The company's book value per share is $22.42.
Technical Analysis
52-Week High/Low: The 52-week high for RMAX is $13.70 and the 52-week low is $6.94.
Moving Averages: The 50-day moving average is $12.00 and the 200-day moving average is $9.59.
Beta: The stock has a beta of 1.359, indicating higher volatility than the market.
Short Term Outlook
In the short term, RMAX is facing headwinds due to rising interest rates and a slowing housing market. The company's revenue and earnings may continue to be impacted in the coming quarters.
Long Term Outlook
The long-term outlook for RMAX is more positive. The company has a strong brand recognition and a global presence. As the housing market recovers, RMAX is well-positioned to benefit from increased demand for real estate services.
Analyst Recommendations
Analysts have a "Hold" rating on RMAX with a target price of $9.75. The target price implies a potential downside of 21% from the current stock price. Five analysts recommend holding the stock, while two recommend selling.
